MDGL - GLP-1 drugs linked to reduced dementia risk: study
2024-06-22 11:00:00 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: The Party Is Probably Nearing The End
- Novo Nordisk: Leading The Fight Against Diabetes And Obesity
- Eli Lilly And Alzheimer's Disease: The Paucity Of Progress
- ResMed, Philips under pressure as Eli Lilly seeks sleep indication for weight loss drug
- Lilly weight loss drug tirzepatide meets primary endpoint in sleep apnea study